Diko : en:comorbidities and complications 10:presence or identity:point in time:^patient:nominal

en:comorbidities and complications 10:presence or identity:point in time:^patient:nominal

Catégories

Nom

Informations lexicales

Langue:anglais

Informations sémantiques

source:wiki

Liens externes

›

umls:C1625748

Associations d'idées

[F]

›

en:coding system.current:type:pt:race:nom

•

en:address at cancer xxx dx:xad:pt:^patient:nom

•

en:3rd course treatment:prid:pt:subsequent cancer rx:nom

•

en:collaborative staging metastasis at diagnosis - lung involvement:prid:pt:cancer.xxx:nom

•

en:collaborative staging post treatment metastasis at diagnosis:prid:pt:cancer.xxx:nom

•

en:coding system.original.seer:id:pt:cancer registry:nom

•

en:coding system.current.seer:id:pt:cancer registry:nom

•

en:collaborative staging pre treatment extension:prid:pt:cancer.xxx:nom

•

en:stage &or prognostic factors section:-:point in time:^patient:set:naaccr v.11

•

en:coc site & type override flag:arb:pt:cancer case.xxx:ord

•

en:coding system used:prid:pt:cancer.xxx pediatric staging:nom

•

en:coding system:type:pt:census tract at cancer xxx dx.alternate:nom

•

en:behavior icd-o-1:prid:pt:cancer.xxx:nom

•

en:4th course treatment.surgery:prid:pt:subsequent cancer rx:nom

•

en:4th course treatment.other therapy:prid:pt:subsequent cancer rx:nom

•

en:behavior icd-o-3:prid:pt:cancer.xxx:nom

•

en:2nd course treatment.other therapy:prid:pt:subsequent cancer rx:nom

•

en:3rd course treatment.biological response modifier therapy:prid:pt:subsequent cancer rx:nom

•

en:alternate census tract at cancer xxx dx:id:pt:^patient:nom

•

en:collaborative staging post treatment extension:prid:pt:cancer.xxx:nom

•

en:cancer-directed surgery 98-02:anatomy:point in time:cancer.to be specified in another part of the message:nominal

•

en:cancer registry:type:point in time:naaccr message:nominal

•

en:chemotherapy:prid:pt:cancer.xxx:nom

•

en:collaborative staging pre treatment metastasis at diagnosis:prid:pt:cancer.xxx:nom

•

en:stage &or prognostic factors section:-:point in time:^patient:set:naaccr v.12

•

en:collaborative staging pre treatment regional nodes evaluation:prid:pt:cancer.xxx:nom

•

en:cancer identification section:-:point in time:^patient:set:naaccr v.12

•

en:boost radiation treatment modality:prid:pt:radiation.rx:nom

•

en:age at cancer dx:number:point in time:cancer.to be specified in another part of the message:quantitative

•

en:cancer conference.presentation status at reporting facility:type:point in time:cancer.to be specified in another part of the message:nominal

•

en:3rd course treatment.hormonal therapy:prid:pt:subsequent cancer rx:nom

•

en:4th course treatment.chemotherapy:prid:pt:subsequent cancer rx:nom

•

en:collaborative staging version.first:prid:pt:cancer.xxx:nom

•

en:coding system.original:type:pt:cancer.xxx.morphology:nom

•

en:cancer identification battery:cmplx:pt::multi

•

en:collaborative staging site-specific factor 20:prid:pt:cancer.xxx:nom

•

en:coding system.original:type:pt:cancer.xxx.anatomic site:nom

•

en:collaborative staging site-specific factor 21:prid:pt:cancer.xxx:nom

•

en:collaborative staging site-specific factor 12:prid:pt:cancer.xxx:nom

•

en:collaborative staging pre treatment tumor size and extension evaluation:prid:pt:cancer.xxx:nom

•

en:chemotherapy rx:type:point in time:cancer.to be specified in another part of the message:nominal

•

en:cancer hx:find:pt:^family member:nar

•

en:archive facility identification number npi:id:pt:cancer.xxx:nom

•

en:2nd course treatment:type:pt:subsequent cancer rx:nom

•

en:2nd course treatment.chemotherapy:prid:pt:subsequent cancer rx:nom

•

en:3rd course treatment.radiation:prid:pt:subsequent cancer rx:nom

•

en:birthplace:identifier:point in time:^patient:nominal

•

en:cause of death:presence or identity:point in time:^patient:nominal

•

en:collaborative staging metastasis at diagnosis - brain involvement:prid:pt:cancer.xxx:nom

•

en:cancer outcome status:type:point in time:cancer.to be specified in another part of the message:nominal

•

en:date of death:time stamp -- date and time:point in time:^patient:quantitative

•

en:collaborative staging metastasis at diagnosis:prid:pt:cancer.xxx:nom

•

en:2nd course treatment.surgery.other regional disease:prid:pt:cancer.xxx:nom

•

en:census tract certainty 1970&80&90:type:point in time:census tract:nominal:*

•

en:derived seer summary stage 1977:prid:pt:cancer.xxx:nom

•

en:derived american joint committee on cancer n:presence or identity:point in time:cancer.to be specified in another part of the message:nominal

•

en:derived pre treatment-7 m descriptor:prid:pt:cancer.xxx:nom

•

en:surgical operation date:tmstp:pt:cancer.xxx:qn

•

en:behavior icd-o-2:prid:pt:cancer.xxx:nom

•

en:regional lymph nodes positive:num:pt:cancer.xxx:qn

•

en:regional lymph nodes examined:num:pt:cancer.xxx:qn

◀

‹

en:behavior icd-o-1:prid:pt:cancer.xxx:nom

•

en:surgical operation date:tmstp:pt:cancer.xxx:qn

•

en:derived pre treatment-7 m descriptor:prid:pt:cancer.xxx:nom

•

en:date of death:time stamp -- date and time:point in time:^patient:quantitative

•

en:collaborative staging site-specific factor 20:prid:pt:cancer.xxx:nom

•

en:collaborative staging site-specific factor 12:prid:pt:cancer.xxx:nom

•

en:coding system.current:type:pt:race:nom

•

en:regional lymph nodes examined:num:pt:cancer.xxx:qn

•

en:cancer outcome status:type:point in time:cancer.to be specified in another part of the message:nominal

•

en:coding system.original:type:pt:cancer.xxx.anatomic site:nom

•

en:age at cancer dx:number:point in time:cancer.to be specified in another part of the message:quantitative

•

en:behavior icd-o-2:prid:pt:cancer.xxx:nom

•

en:derived american joint committee on cancer n:presence or identity:point in time:cancer.to be specified in another part of the message:nominal

•

en:4th course treatment.chemotherapy:prid:pt:subsequent cancer rx:nom

•

en:collaborative staging version.first:prid:pt:cancer.xxx:nom

•

en:derived seer summary stage 1977:prid:pt:cancer.xxx:nom

•

en:2nd course treatment.chemotherapy:prid:pt:subsequent cancer rx:nom

•

en:collaborative staging site-specific factor 21:prid:pt:cancer.xxx:nom

•

en:cancer identification battery:cmplx:pt::multi

•

en:archive facility identification number npi:id:pt:cancer.xxx:nom

•

en:2nd course treatment.other therapy:prid:pt:subsequent cancer rx:nom

•

en:2nd course treatment.surgery.other regional disease:prid:pt:cancer.xxx:nom

•

en:address at cancer xxx dx:xad:pt:^patient:nom

•

en:regional lymph nodes positive:num:pt:cancer.xxx:qn

•

en:cancer hx:find:pt:^family member:nar

•

en:3rd course treatment.radiation:prid:pt:subsequent cancer rx:nom

•

en:collaborative staging metastasis at diagnosis:prid:pt:cancer.xxx:nom

•

en:collaborative staging pre treatment regional nodes evaluation:prid:pt:cancer.xxx:nom

•

en:collaborative staging pre treatment tumor size and extension evaluation:prid:pt:cancer.xxx:nom

•

en:coding system used:prid:pt:cancer.xxx pediatric staging:nom

•

en:chemotherapy:prid:pt:cancer.xxx:nom

•

en:coding system.original.seer:id:pt:cancer registry:nom

•

en:behavior icd-o-3:prid:pt:cancer.xxx:nom

•

en:cancer-directed surgery 98-02:anatomy:point in time:cancer.to be specified in another part of the message:nominal

•

en:birthplace:identifier:point in time:^patient:nominal

•

en:4th course treatment.other therapy:prid:pt:subsequent cancer rx:nom

•

en:3rd course treatment.hormonal therapy:prid:pt:subsequent cancer rx:nom

•

en:boost radiation treatment modality:prid:pt:radiation.rx:nom

•

en:cancer registry:type:point in time:naaccr message:nominal

•

en:cause of death:presence or identity:point in time:^patient:nominal

•

en:chemotherapy rx:type:point in time:cancer.to be specified in another part of the message:nominal

•

en:collaborative staging post treatment metastasis at diagnosis:prid:pt:cancer.xxx:nom

•

en:2nd course treatment:type:pt:subsequent cancer rx:nom

•

en:coding system.original:type:pt:cancer.xxx.morphology:nom

•

en:collaborative staging pre treatment metastasis at diagnosis:prid:pt:cancer.xxx:nom

•

en:collaborative staging pre treatment extension:prid:pt:cancer.xxx:nom

•

en:cancer identification section:-:point in time:^patient:set:naaccr v.12

•

en:coding system.current.seer:id:pt:cancer registry:nom

•

en:alternate census tract at cancer xxx dx:id:pt:^patient:nom

•

en:cancer conference.presentation status at reporting facility:type:point in time:cancer.to be specified in another part of the message:nominal

•

en:3rd course treatment.biological response modifier therapy:prid:pt:subsequent cancer rx:nom

•

en:3rd course treatment:prid:pt:subsequent cancer rx:nom

•

en:4th course treatment.surgery:prid:pt:subsequent cancer rx:nom

•

en:coding system:type:pt:census tract at cancer xxx dx.alternate:nom

•

en:collaborative staging metastasis at diagnosis - brain involvement:prid:pt:cancer.xxx:nom

•

en:collaborative staging metastasis at diagnosis - lung involvement:prid:pt:cancer.xxx:nom

•

en:collaborative staging post treatment extension:prid:pt:cancer.xxx:nom

•

en:stage &or prognostic factors section:-:point in time:^patient:set:naaccr v.11

•

en:stage &or prognostic factors section:-:point in time:^patient:set:naaccr v.12

•

en:census tract certainty 1970&80&90:type:point in time:census tract:nominal:*

•

en:coc site & type override flag:arb:pt:cancer case.xxx:ord

◀

Génériques

[F] [H]

›

en:clinical attribute

• Mathieu Lafourcade • LIRMM (données libres en Creative Commons - C0 domaine public) •

• This page link : https://www.jeuxdemots.org/diko.php?gotermid=7998375 • caches: c1=8 c2=64 c3=62

+/-

♥

po

la

ti

le

as

ku

co

lo

to

ta

ta

xe

po

li

?!

!?

[Vider le cache]

A propos

Champs masqués